2012 Midyear Clinical Meeting
Click here to go to the previous page
Controversial ICU Prophylactic Drug Therapies: Playing With a Royal Flush or Bluffing On a Busted Hand
Track:
Education Sessions (CE)
Program Code: 240-L01
Date: Thursday, December 6, 2012
Time: 9:30 AM to 11:30 AM EST
Location:
Mandalay Bay D, Level 2, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Brian Barnes,
PharmD, MS, Associate Dean/Associate Professor,
The University of Kansas, School of Pharmacy
|
Dr. Brian J. Barnes is an Associate Professor and Associate Dean for Academic Affairs with The University of Kansas School of Pharmacy. He has a secondary appointment with the University of Kansas, School of Medicine and leads an interdisciplinary collaborative research group that investigates the influence of pharmacotherapy on the health-outcomes of patients undergoing cardiac surgery at The University of Kansas Hospital. He received his Doctor of Pharmacy from the University of Kansas School of Pharmacy and Masters of Science in Clinical Research from the University of Kansas, School of Medicine, Department of Preventive Medicine and Public Health. His postdoctoral training includes Pharmacy Practice and Critical Care specialty residencies at Barnes-Jewish Hospital at Washington University Medical Center; and completion of the University of Kansas, School of Medicines NIH K30 Clinical Research Curriculum Program.
|
Mitchell Buckley,
Pharm.D., FCCM, Clinical Pharmacy Specialist,
Banner Good Samaritan Medical Center
|
Dr. Buckley, Pharm.D, FCCM, BCPS, currently practices as a clinical pharmacist in the medical intensive care unit and serves as the PGY1 Residency Program Director at Banner Good Samaritan Medical Center in Phoenix, AZ. Dr. Buckley received his Doctor of Pharmacy degree from the University of Iowa in 2002. He completed an ASHP-accredited PGY1 Pharmacy Practice Residency at Shawnee Mission Medical Center and a PGY2 Critical Care Specialty Residency at the University of Arizona in 2004. He has authored several peer-reviewed publications in pharmacy and medical journals as well as book chapters relating to critical care. He is actively involved in national as well as regional pharmacy organizations and has served as Chair for the Patient Safety and Research Committees within the Society of Critical Care Medicine. Dr. Buckleys interests include pulmonary arterial hypertension, septic shock, ventilator-associated pneumonia, and medication safety in critically ill patients.
|
William Dager,
PharmD, BCPS, Pharmacist Specialist,
University of California Davis Medical Center
|
William E. Dager, Pharm.D, BCPS (AQ Cardiology)
FCSHP, FCCP, FCCM, FASHP
Pharmacist Specialist, UC Davis Medical Center (UCDMC)
Clinical Professor of Pharmacy
University of California, San Francisco
Clinical Professor of Medicine
School of University of California, Davis
Clinical Professor of Pharmacy, Touro School of Pharmacy
William E. Dager, received his Pharm.D. from the University of California, San Francisco (UCSF) and completed a residency at UCDMC. He also completed a Nephrology Pharmaceutical Care Preceptorship at the University of Pittsburgh, School of Pharmacy. He is a board certified pharmacotherapy specialist with added qualifications in cardiology, who is a clinical specialist at UCDMC where he manages difficult cases in anticoagulation, pharmacokinetics or other critical care related situations. He is the director of the PGY-2 residency in cardiology. He currently holds four academic positions primarily as volunteer faculty.
Dr Dager is a recipient of multiple teaching and mentoring awards including the ACCP Best Practice award. He is a reviewer and/or editorial board member for multiple medical journals including chair of the Editorial Advisory Board panel on anticoagulation for the Annals of Pharmacotherapy. He is also a site coordinator for the ASHP foundation anticoagulation preceptorship.
Dr Dager has authored numerous articles, reviews book chapters in including the ASHP Anticoagulation Therapy POC guide. He is an active lecturer and has research interests involving anticoagulation, critical care, cardiovascular disease and pharmacokinetics/pharmacodynamics.
|
Stacy Voils,
PharmD, BCPS, Clinical Pharmacy Specialist,
Virginia Commonwealth University Health System
|
Dr. Voils is a critical care specialist in neuroscience at Virginia Commonwealth University Health System, Medical College of Virginia Campus. He is board certified in pharmacotherapy and research/clinical interests include hemostasis, traumatic brain injury, stroke, epidemiology and biostatistics.
|
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Mitchell Buckley,
Pharm.D., FCCM, Clinical Pharmacy Specialist,
Banner Good Samaritan Medical Center
|
Dr. Buckley, Pharm.D, FCCM, BCPS, currently practices as a clinical pharmacist in the medical intensive care unit and serves as the PGY1 Residency Program Director at Banner Good Samaritan Medical Center in Phoenix, AZ. Dr. Buckley received his Doctor of Pharmacy degree from the University of Iowa in 2002. He completed an ASHP-accredited PGY1 Pharmacy Practice Residency at Shawnee Mission Medical Center and a PGY2 Critical Care Specialty Residency at the University of Arizona in 2004. He has authored several peer-reviewed publications in pharmacy and medical journals as well as book chapters relating to critical care. He is actively involved in national as well as regional pharmacy organizations and has served as Chair for the Patient Safety and Research Committees within the Society of Critical Care Medicine. Dr. Buckleys interests include pulmonary arterial hypertension, septic shock, ventilator-associated pneumonia, and medication safety in critically ill patients.
|
Description
Reducing the Stressed Stomach: Optimal Stress Ulcer Prophylaxis Strategies, Mitchell S. Buckley, PharmD, FCCM
Getting the Heart Out of the Fast Lane: Novel Therapies in Preventing Postoperative Atrial Fibrillation, Brian J. Barnes, PharmD, MS
Preventing VTE: Keeping the Blood Flowing, William E. Dager, PharmD, BCPS, FASHP
Novel Anti-Epileptic Medications for Seizure Prevention in Patients with Traumatic Brain Injury, Stacy Voils, PharmD, BCPS
- Compare the efficacy of novel pharmacologic agents versus standard therapies in the prophylaxis of atrial fibrillation after cardiac surgery.
- Design an evidence-based pharmacotherapy regimen for stress ulcer prevention in the critically ill patient.
- Evaluate the different approaches to providing thromboprophylaxis in the critically ill.
- Evaluate the literature for post-traumatic seizure prophylaxis focusing on the safety and effectiveness of newer anti-epileptic medications.
